Precision oncology is reshaping care for patients with non-small cell cancer (NSCLC). Recent advances in perioperative treatment approaches, including the use of immunotherapy and other novel targeted therapies, are improving outcomes for patients with NSCLC. However, multidisciplinary coordination and accurate interpretation and application of molecular testing results are crucial for individualized treatment strategies. Tune in this webcast as experts discuss the latest clinical safety and efficacy data on perioperative treatments for NSCLC, and expert recommendations for biomarker testing, treatment selection, and adverse event management in the federal, public, and government health settings.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/targeting-new-era-precision-oncology-treating-solid-tumors-federal-public
- Start Date: 2024-12-30 06:00:00
- End Date: 2024-12-30 06:00:00
- Credit Details: AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Aveo Pharmaceuticals - Amount: 2083.33 - Is Kind Support: False Source: Merck (Any division) - Amount: 16666.67 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology
Subscribe
Login
0 Comments
Oldest